A period of austerity public spending in England to note the changes in frailty in individuals aged 50 years and above.
FDA’s Troy Tazbaz returns to Oracle after a short stint shaping health AI rules
Troy Tazbaz, the outgoing director of the Food and Drug Administration’s Digital Health Center of Excellence, is returning to Oracle as a senior vice president